Protalix BioTherapeutics GAAP EPS of $0.00 misses by $0.03, revenue of $15.66M beats by $2.18M

1 hour ago 1

Protalix BioTherapeutics press release (NYSE:PLX): Q2 GAAP EPS of $0.00 misses by $0.03.
Revenue of $15.66M (+16.3% Y/Y) beats by $2.18M.
At June 30, 2025, we had $33.4 million in cash and cash equivalents and short-term bank deposits.

Recommended For You